H.C. Wainwright analyst Andres Maldonado lowered the firm’s price target on Erasca to $5 from $8 and keeps a Buy rating on the shares. The analyst says the company’s In-licensing of new programs shakes up pipeline with another round of reprioritization.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ERAS:
- Erasca 86.5M share Secondary priced at $1.85
- Erasca announces strategic in-licensing of RAS-targeting franchise
- Erasca Announces Pricing of Underwritten Offering of Common Stock
- Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise
- Erasca files to sell 21.07M shares of common stock for holders